Article
US FDA grants accelerated approval for Incyte's skin cancer therapy
Rating:
0.0
Views:
50
Likes:
1
Library:
1
Incyte Corp said on Wednesday its monoclonal antibody, Zynyz, has won accelerated approval from the U.S. health regulator for treating a rare and aggressive type of skin cancer in adults.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value